alcohol and glp 1 medications GLP-1 RAs may reduce alcohol-related hospitalization risk How alcohol affects GLP-1 weight-loss

In the absence of population-specific data, clinical use should be accompanied by vigilant monitoring for class-wide effects (particularly gastrointestinal symptoms) and agent-specific concerns, with dose titration individualized to tolerability

doi: 10.1073/pnas.1201191109 187 SongC.WangH

But for many people, an injectable medication like Wegovy ( semaglutide ) can be essential for achieving weight loss and reducing cardiovascular risk

Since a high dose of semaglutide (0.1 mg/kg) was examined 17 when using the drug in animals to reduce alcohol-seeking behavior, adjusting the dosage to obtain the desired effect while decreasing the potentially harmful effects is recommended